Cargando…

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

BACKGROUND: Rift Valley Fever (RVF) is a viral zoonosis that historically affects livestock production and human health in sub-Saharan Africa, though epizootics have also occurred in the Arabian Peninsula. Whilst an effective live-attenuated vaccine is available for livestock, there is currently no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warimwe, George M, Lorenzo, Gema, Lopez-Gil, Elena, Reyes-Sandoval, Arturo, Cottingham, Matthew G, Spencer, Alexandra J, Collins, Katharine A, Dicks, Matthew DJ, Milicic, Anita, Lall, Amar, Furze, Julie, Turner, Alison V, Hill, Adrian VS, Brun, Alejandro, Gilbert, Sarah C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235025/ https://www.ncbi.nlm.nih.gov/pubmed/24304565 http://dx.doi.org/10.1186/1743-422X-10-349

Ejemplares similares

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016)

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
por: Warimwe, George M., et al.
Publicado: (2016)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
por: Dicks, Matthew D.J., et al.
Publicado: (2015)

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
por: Dicks, Matthew D. J., et al.
Publicado: (2012)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, Matthew D. J., et al.
Publicado: (2015)

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2012)

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis
por: Anywaine, Zacchaeus, et al.
Publicado: (2022)

Rift Valley Fever in Goats, Cameroon
por: LeBreton, Matthew, et al.
Publicado: (2006)

Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset
por: Wichgers Schreur, Paul J., et al.
Publicado: (2022)

Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep
por: Matsiela, Matome Selina, et al.
Publicado: (2023)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1()
por: Douglas, Alexander D., et al.
Publicado: (2010)

The Pathogenesis of Rift Valley Fever
por: Ikegami, Tetsuro, et al.
Publicado: (2011)

Rift Valley Fever Encephalitis
por: Alrajhi, Abdulrahman A., et al.
Publicado: (2004)

Rift Valley Fever in Chad
por: Ringot, David, et al.
Publicado: (2004)

Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir
por: Borrego, Belén, et al.
Publicado: (2019)

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
por: Kim, Young Chan, et al.
Publicado: (2020)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice
por: Li, Yuetao, et al.
Publicado: (2020)

Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula
por: Samy, Abdallah M., et al.
Publicado: (2017)

RIFT VALLEY FEVER: LESSONS TO BE LEARNED
por: Alam, Awatif A., et al.
Publicado: (2000)

Rift Valley Fever in Namibia, 2010
por: Monaco, Federica, et al.
Publicado: (2013)

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
por: Clark, Madeleine H. A., et al.
Publicado: (2018)

Rift Valley and West Nile Virus Antibodies in Camels, North Africa
por: El-Harrak, Mehdi, et al.
Publicado: (2011)

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
por: Wright, Daniel, et al.
Publicado: (2020)

The 2007 Rift Valley Fever Outbreak in Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2011)

Rift Valley Fever, Mayotte, 2007–2008
por: Sissoko, Daouda, et al.
Publicado: (2009)

Molecular Biology of Rift Valley Fever Virus
por: Bouloy, Michele, et al.
Publicado: (2010)

Rift Valley Fever Potential, Arabian Peninsula
por: Anyamba, Assaf, et al.
Publicado: (2006)

Molecular Epidemiology of Rift Valley Fever Virus
por: Grobbelaar, Antoinette A., et al.
Publicado: (2011)

An Assembly Model of Rift Valley Fever Virus
por: Rusu, Mirabela, et al.
Publicado: (2012)

Rift Valley Fever, Sudan, 2007 and 2010
por: Aradaib, Imadeldin E., et al.
Publicado: (2013)

Reemergence of Rift Valley Fever, Mauritania, 2010
por: Faye, Ousmane, et al.
Publicado: (2014)

The Risk of Nosocomial Transmission of Rift Valley Fever
por: Al-Hamdan, Nasser A., et al.
Publicado: (2015)

Sociocultural and Economic Dimensions of Rift Valley Fever
por: Muga, Geoffrey Otieno, et al.
Publicado: (2015)

Randomized Controlled Field Trial to Assess the Immunogenicity and Safety of Rift Valley Fever Clone 13 Vaccine in Livestock
por: Njenga, M. Kariuki, et al.
Publicado: (2015)

Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome
por: Ayers, Victoria B., et al.
Publicado: (2023)

Immunogenicity of a freeze-dried combined vaccine against Rift Valley fever and bovine ephemeral fever in cattle
por: Aly, Naglaa Ebrahim, et al.
Publicado: (2023)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: López-Gil, Elena, et al.
Publicado: (2020)

Development and validation of a pen side test for Rift Valley fever
por: Cêtre-Sossah, Catherine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gncnkm1r5hscm3i78rijol0efp